Forge Biologics to Present at 40th Annual J.P. Morgan Healthcare Conference - Forge Biologics

Forge Biologics to Present at 40th Annual J.P. Morgan Healthcare Conference


COLUMBUS, Ohio – January 5, 2022 Forge Biologics, a gene therapy-focused contract development and manufacturing organization, announced today that Timothy J. Miller, Ph.D., CEO, President, and Co-Founder, will present at the 40th Annual J.P. Morgan Healthcare Conference virtually on Tuesday, January 11, 2022, at 10:00 a.m. Eastern Time.

The presentation will be available on the Events section of the Forge Biologics website ( on January 11 and for 30 days following the event.

About Forge Biologics
Forge Biologics is a hybrid gene therapy contract manufacturing and therapeutics development company. Forge’s mission is to enable access to life changing gene therapies and help bring them from idea to reality. Forge has a 175,000 square foot facility in Columbus, Ohio, The Hearth, to serve as its headquarters. The Hearth is a custom-designed cGMP facility dedicated to AAV vector manufacturing and will host end-to-end manufacturing services to accelerate gene therapy programs from preclinical through clinical and commercial stage manufacturing. By taking a patients-first approach, Forge aims to accelerate the timelines of these transformative medicines for those who need them the most. To learn more, visit

Media Inquiries 
Marina Corleto, M.N.O. – Forge Biologics
Senior Manager, Marketing and Communications   

Families and Clinician Inquiries
Maria Escolar, M.D., M.S. – Forge Biologics
Chief Medical Officer

Business Development  
Magdalena Tyrpien, M.B.A. – Forge Biologics
Senior Vice President, Head of Business Development   

Client Development
John Maslowski, M.S. – Forge Biologics
Chief Commercial Officer

Investor Relations  
Christina Perry, M.S.A., C.P.A. – Forge Biologics
Senior Vice President, Finance and Investor Relations   


0/5 (0 Reviews)